Expiring contracts
Contracts whose period of performance ends soon. When these expire, the work usually gets recompeted — this is your pipeline of future opportunities.
Filters
17 contracts ending in the next 0–18 months (0.56 seconds)
- 70RSAT25FR0000014 ↗$797K
SECTION 2(D) - TO AWARD AND FULLY FUND THE NATIONAL BIODEFENSE ANALYSIS AND COUNTERMEASURES CENTER (NBACC) ANALYTIC TASK (AT) FOR STERILIZED LAB WASTE DISPOSAL AND SITE SERVICES FOR 2025 (THE NBACC II EXTENSION).
- Ends
- Nov 29, 2026
- Started
- May 15, 2025
- Agency
- Office Of Procurement Operations
- NAICS
- 541711
- 75N93022F00001 ↗$564K
TASK A68 SCREENING VACCINE (AND OTHER BIOLOGICS) PLATFORM TECHNOLOGIES USING CORONAVIRUS MOUSE IMMUNOGENICITY AS A MODEL SYSTEM
- Ends
- Nov 29, 2026
- Started
- May 22, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541711
- W81XWH15C0048 ↗$3.5M
FREEZE DRIED PLASMA CLINICAL TRIAL FOR BLA RESUBMISSION.
- Ends
- Dec 30, 2026
- Started
- Mar 29, 2015
- Agency
- Defense Health Agency
- NAICS
- 541711
CLINICAL MONITORING INITIATIVE (CMI) FOR VRC 316, 317, 320, 603
- Ends
- Dec 30, 2026
- Started
- Apr 29, 2019
- Agency
- National Institutes Of Health
- NAICS
- 541711
DNAE / PATHOGEN IDENTIFICATION FROM SPECIMEN, VIA CAPTURE, EXTRACTION AND SEQUENCING (PISCES)
- Ends
- Dec 30, 2026
- Started
- Sep 27, 2016
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541711
NICHD: R&D: CLINICAL TREATMENT OF NESTORONE GEL AND TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE
- Ends
- Dec 30, 2026
- Started
- Sep 13, 2015
- Agency
- National Institutes Of Health
- NAICS
- 541711
- W911QY13C0056 ↗$-317K
EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 12 MARCH 2026 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
- Ends
- Mar 10, 2027
- Started
- May 8, 2013
- Agency
- Department Of The Army
- NAICS
- 541711
- 70RSAT26FR0000002 ↗$2.6M
NEW FFRDC NBACC 2026 INSURANCE
- Ends
- Mar 17, 2027
- Started
- Mar 18, 2026
- Agency
- Office Of Procurement Operations
- NAICS
- 541711
- HHSO100201600009C ↗$-280K
NO COST EXTENSION FOR OPTION 16 (CLIN 0018) AND REVISE KEY PERSONNEL.
- Ends
- Mar 30, 2027
- Started
- Jun 16, 2016
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541711
- HHSN275201700002C ↗$10.7M
DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT
- Ends
- May 27, 2027
- Started
- Jul 27, 2017
- Agency
- National Institutes Of Health
- NAICS
- 541711
- 75N93024F00002 ↗$1.7M
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES
- Ends
- Jun 23, 2027
- Started
- Jun 24, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541711
- 70RSAT26FR0000017 ↗$2.0M
NBACC II EXTENSION WORK FOR OTHERS (WFO) TASK ORDER FOR THE EQUIPMENT ACQUISITION AND DEMONSTRATION PROJECT PLANNING FOR GENERATIVE UNCONSTRAINED INTELLIGENT DRUG ENGINEERING (GUIDE), PHASE II.
- Ends
- Jul 1, 2027
- Started
- Jul 2, 2026
- Agency
- Office Of Procurement Operations
- NAICS
- 541711
- 75N93024F00001 ↗$716K
PRECLINICAL MODELS OF INFECTIOUS DISEASES
- Ends
- Jul 9, 2027
- Started
- Jul 10, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541711
- HHSO100201700020C ↗$-331.7M
NO COST MODIFICATION TO REVISE THE JOINT OVERSIGHT COMMITTEE MEMBERS AND EXTEND THE PERIOD OF PERFORMANCE FOR CLIN 0001 TO SEPT 25, 2027.
- Ends
- Sep 23, 2027
- Started
- Sep 20, 2017
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541711
- HHSO100201700016C ↗$2.7M
NO COST MOD TO REVISE THE CONTRACT SECTIONS: ARTICLE B.2.1., ARTICLE C.1., ARTICLE F.4, , ARTICLE G.4. AND THE STATEMENT OF WORK.
- Ends
- Sep 28, 2027
- Started
- Sep 29, 2017
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541711
- HHSO100201600038C ↗$47.5M
THE PURPOSE OF THIS MODIFICATION IS TO UPDATE COST SHARE AMOUNT AND ADD SUPPLEMENTAL FUNDING TO CLIN 0002.
- Ends
- Sep 29, 2027
- Started
- Sep 14, 2016
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541711
THE PURPOSE OF THIS BILATERAL ADMINISTRATIVE MODIFICATION IS TO CHANGE THE KEY PERSONNEL AND ADD AN ALTERNATE COR. 1. CHANGE ARTICLE G.2. CONTRACTING OFFICER'S REPRESENTATIVE (COR) AND ALTERNATIVE CONTRACTING OFFICER'S REPRESENTATIVE (COR)
- Ends
- Sep 29, 2027
- Started
- Sep 27, 2015
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541711
| PIID | Contractor | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|---|
| 70RSAT25FR0000014 ↗ | Battelle National Biodefense Institute, LLC | SECTION 2(D) - TO AWARD AND FULLY FUND THE NATIONAL BIODEFENSE ANALYSIS AND COUNTERMEASURES CENTER (NBACC) ANALYTIC TASK (AT) FOR STERILIZED LAB WASTE DISPOSAL AND SITE SERVICES FOR 2025 (THE NBACC II EXTENSION). | Office Of Procurement Operations | 541711 | $797K | May 15, 2025 | Nov 29, 2026 |
| 75N93022F00001 ↗ | University Of North Carolina At Chapel Hill | TASK A68 SCREENING VACCINE (AND OTHER BIOLOGICS) PLATFORM TECHNOLOGIES USING CORONAVIRUS MOUSE IMMUNOGENICITY AS A MODEL SYSTEM | National Institutes Of Health | 541711 | $564K | May 22, 2022 | Nov 29, 2026 |
| W81XWH15C0048 ↗ | Westat, INC. | FREEZE DRIED PLASMA CLINICAL TRIAL FOR BLA RESUBMISSION. | Defense Health Agency | 541711 | $3.5M | Mar 29, 2015 | Dec 30, 2026 |
| 75N93019F00132 ↗ | The Emmes Company, LLC | CLINICAL MONITORING INITIATIVE (CMI) FOR VRC 316, 317, 320, 603 | National Institutes Of Health | 541711 | $0 | Apr 29, 2019 | Dec 30, 2026 |
| HHSO100201600017C ↗ | Dnae Group Holdings Limited | DNAE / PATHOGEN IDENTIFICATION FROM SPECIMEN, VIA CAPTURE, EXTRACTION AND SEQUENCING (PISCES) | Office Of Assistant Secretary For Preparedness And Response | 541711 | $0 | Sep 27, 2016 | Dec 30, 2026 |
| HHSN27500007 ↗ | Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center | NICHD: R&D: CLINICAL TREATMENT OF NESTORONE GEL AND TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE | National Institutes Of Health | 541711 | $0 | Sep 13, 2015 | Dec 30, 2026 |
| W911QY13C0056 ↗ | Dynport Vaccine Company LLC | EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 12 MARCH 2026 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS. | Department Of The Army | 541711 | $-317K | May 8, 2013 | Mar 10, 2027 |
| 70RSAT26FR0000002 ↗ | Battelle National Biodefense Institute, LLC | NEW FFRDC NBACC 2026 INSURANCE | Office Of Procurement Operations | 541711 | $2.6M | Mar 18, 2026 | Mar 17, 2027 |
| HHSO100201600009C ↗ | Cerus Corporation | NO COST EXTENSION FOR OPTION 16 (CLIN 0018) AND REVISE KEY PERSONNEL. | Office Of Assistant Secretary For Preparedness And Response | 541711 | $-280K | Jun 16, 2016 | Mar 30, 2027 |
| HHSN275201700002C ↗ | The Emmes Company, LLC | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT | National Institutes Of Health | 541711 | $10.7M | Jul 27, 2017 | May 27, 2027 |
| 75N93024F00002 ↗ | University Of Texas Medical Branch At Galveston | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES | National Institutes Of Health | 541711 | $1.7M | Jun 24, 2024 | Jun 23, 2027 |
| 70RSAT26FR0000017 ↗ | Battelle National Biodefense Institute, LLC | NBACC II EXTENSION WORK FOR OTHERS (WFO) TASK ORDER FOR THE EQUIPMENT ACQUISITION AND DEMONSTRATION PROJECT PLANNING FOR GENERATIVE UNCONSTRAINED INTELLIGENT DRUG ENGINEERING (GUIDE), PHASE II. | Office Of Procurement Operations | 541711 | $2.0M | Jul 2, 2026 | Jul 1, 2027 |
| 75N93024F00001 ↗ | Trustees Of Tufts College | PRECLINICAL MODELS OF INFECTIOUS DISEASES | National Institutes Of Health | 541711 | $716K | Jul 10, 2024 | Jul 9, 2027 |
| HHSO100201700020C ↗ | Regeneron Pharmaceuticals INC | NO COST MODIFICATION TO REVISE THE JOINT OVERSIGHT COMMITTEE MEMBERS AND EXTEND THE PERIOD OF PERFORMANCE FOR CLIN 0001 TO SEPT 25, 2027. | Office Of Assistant Secretary For Preparedness And Response | 541711 | $-331.7M | Sep 20, 2017 | Sep 23, 2027 |
| HHSO100201700016C ↗ | Regeneron Pharmaceuticals INC | NO COST MOD TO REVISE THE CONTRACT SECTIONS: ARTICLE B.2.1., ARTICLE C.1., ARTICLE F.4, , ARTICLE G.4. AND THE STATEMENT OF WORK. | Office Of Assistant Secretary For Preparedness And Response | 541711 | $2.7M | Sep 29, 2017 | Sep 28, 2027 |
| HHSO100201600038C ↗ | Hoffmann-La Roche INC. | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE COST SHARE AMOUNT AND ADD SUPPLEMENTAL FUNDING TO CLIN 0002. | Office Of Assistant Secretary For Preparedness And Response | 541711 | $47.5M | Sep 14, 2016 | Sep 29, 2027 |
| HHSO100201500021C ↗ | Polynovo Biomaterials Pty Ltd | THE PURPOSE OF THIS BILATERAL ADMINISTRATIVE MODIFICATION IS TO CHANGE THE KEY PERSONNEL AND ADD AN ALTERNATE COR. 1. CHANGE ARTICLE G.2. CONTRACTING OFFICER'S REPRESENTATIVE (COR) AND ALTERNATIVE CONTRACTING OFFICER'S REPRESENTATIVE (COR) | Office Of Assistant Secretary For Preparedness And Response | 541711 | $0 | Sep 27, 2015 | Sep 29, 2027 |